Media - Chasing My Cure
 
 

Press and Media Appearances

New York Times: his doctors were stumped then he took over

2/4/2017: They called him the Beast.David Fajgenbaum was the fittest of his friends at the University of Pennsylvania’s medical school, a 6-foot-3 gym addict and former quarterback at Georgetown. His mammoth hands seemed more suited to spiraling footballs than...

Today Show: doctor with rare disease racing to save his own life

1/14/2018: David Fajgenbaum, a 32-year-old doctor at the University of Pennsylvania, is racing to find a cure for Castleman disease, an illness that’s “like a mix between an autoimmune disease and a cancer.” Fajgenbaum is not only devoting his life to this cause for other patients – he’s been battling the rare and deadly disease himself since 2010. TODAY’s Dylan Dreyer has this week’s Sunday Spotlight...

6ABC: new bill could help patients with rare diseases find effective treatments

7/11/2016: WEST PHILADELPHIA (WPVI) -- One local doctor is urging lawmakers to pass a bill that could help thousands of people with rare diseases to find effective treatments.He's a doctor and a researcher, but he's also a patient battling a rare disease himself.A rare disease means it affects a very small percentage of the population. But all together, about 30 million Americans have one of the 7,000 rare diseases...

Character Lab: think it do it

5/5/2019: David Fajgenbaum didn’t die. He thought he would. He almost did.But he didn’t.What almost killed him was Castleman disease, an immune disorder so rare that David, a medical student when the symptoms first appeared, had never heard of it...

ABC11: doctor in race against time

11/24/2015: PHILADELPHIA (WTVD) -- Looking at family photos, it appears David Fajgenbaum has it all: A medical degree and an MBA from the University of Pennsylvania, a beautiful wife, and a job that keeps his creative juices flowing.But then there are other pictures that tell a much different story - one of a rare and deadly disease with no cure...

Science: young doctor fights to cure his own rare deadly disease

7/13/2016: After the third time he nearly died but before the fourth, David Fajgenbaum embraced a new motto: Think it, do it. “I got out of the hospital with this profound sense of, you need to make the most of every second,” he says. A former college football player with close-cropped dark hair and a firm handshake, Fajgenbaum, 31, is the picture...

 

Articles and Insights

One step closer to my dream…

We Announced the $48.3M Federal Partnership at the White House! [embedyt] https://www.youtube.com/watch?v=3ElaCVvDZfI[/embedyt] It was incredibly special for me to speak at the White House on Wednesday about our funding from the federal government and what it will mean for patients like me. While on stage, I couldn’t help but think back to 14 years ago […]

Read More

2023 Philadelphia Citizen of the Year

I am beyond honored to be named the 2023 Philadelphia Citizen of the Year by The Philadelphia Citizen. This recognition is a testament to our amazing team’s work and the support that so many of you have shared with us! It has been the honor of a lifetime to work with our amazing teams at […]

Read More

Celebrating 10 Years in Remission!

Reflecting on 10 Years in Overtime – Time I Never Thought I’d Have At Every Cure, we are utilizing artificial intelligence to identify the most promising new uses for existing drugs across all 3,000 drugs and 20,000 diseases and we need your help to make the biggest impact possible! Whether it’s forwarding this email to a friend or […]

Read More

A New Chapter of Turning Hope Into Action

Our family grew! We welcomed our second little one into the world On November 5, 2021, we welcomed baby David into the world. He is the sweetest little brother to Amelia. It feels like such a dream to have this incredible family when I think back to when I was on my deathbed 13 years […]

Read More

From Chasing My Cure to Every Cure

Inspired by my journey discovering a drug that could be repurposed to save my life, I co-founded Every Cure in September 2022 to unlock the full potential of existing medicines to treat every disease and every patient possible. I had the opportunity to announce Every Cure’s launch during the Opening Session of the Clinton Global […]

Read More

New England Journal of Medicine published our paper on Cytokine Storm

I’m thrilled to share that my paper on Cytokine Storms with Carl June, MD, was published today in the New England Journal of Medicine! A “cytokine storm” is an immune response that spirals out of control and occurs with Castleman disease, CART, severe COVID19, and other conditions. We developed the first unifying definition of a […]

Read More

First repurposed drug reported to decrease COVID19 mortality

Repurposing existing drugs to treat COVID19 provides our best opportunity to save lives ASAP. As I like to say, we’ve got to teach old dogs new tricks! I know the power of drug repurposing: I’m alive today thanks to a repurposed drug. Given the overlap between COVID19 and Castleman disease, I’ve suspected that treatments used […]

Read More

Our team publishes first paper from CORONA project

With doctors and researchers around the world searching for effective treatments for COVID-19, many drugs approved to treat other diseases are being used in hopes that they’ll be effective against the virus, a use that’s known as “off-label.” A volunteer army that Dr. David Fajgenbaum assembled has catalogued every use documented in medical literature so […]

Read More

What is a cytokine storm?

You’ve probably seen the term “cytokine storm” in the news a lot recently. That’s because COVID19 is able to unleash a cytokine storm in the most sick cases. As someone who has survived 5 deadly COVID19-like cytokine storms due to idiopathic multicentric Castleman disease and who studies cytokine storms in my lab, I thought I’d […]

Read More

Five years worth of cytokine storm research published on the same day

I’m so proud of my team at the University of Pennsylvania’s Center for Study & Treatment of Lymphadenopathies & Cytokine Storms. Today, five years worth of research into mechanisms involved in the idiopathic multicentric Castleman disease (iMCD) cytokine storm, which has major implications for other cytokine storms like COVID19, were published in two high-impact journals. […]

Read More

[Video] Learn how we’re helping in the fight against COVID19

[embedyt] https://www.youtube.com/watch?v=0HFHfTd9-Y8[/embedyt] Check out the above video about our COVID19 drug repurposing work or go to: https://youtu.be/0HFHfTd9-Y8 Thank you to Jimmy Baggott for making this amazing video! #ThinkItDoIt #FromHopeToAction #ChasingMyCure #ChasingCOVIDsCure   David Fajgenbaum, MD, MBA, MSc, is a groundbreaking physician-scientist, disease hunter, speaker, and bestselling author of the acclaimed memoir, Chasing My Cure: A […]

Read More

I wasn’t the first Castleman community member to test a drug on myself

As I’ve shared before, repurposing existing drugs to treat COVID19 (and every other disease) is our best opportunity to save lives as quickly as possible. One drug that is being repurposed and has gotten a lot of attention is tocilizumab (Actemra). As I shared in #ChasingMyCure (excerpt below), it was originally developed by my friend […]

Read More

Why we joined the fight against COVID19. How you can help too.

As I was driving down to North Carolina to visit my family at the beginning of the COVID-19 global pandemic, I found myself hoping and praying that COVID-19 would not have the kind of impact that was being projected. This wasn’t the first time I hoped and prayed for something that felt so out of […]

Read More

Chasing My Cure in the news!

It has been amazing to see all of the incredible press and media attention for Chasing My Cure! Check out the various stories below: Chasing My Cure in the press: Good Morning America, August 26, 2019 Philadelphia Magazine, August 28, 2019 Philadelphia Inquirer, September 5, 2019 Next Big Idea Club—Top 6 Nonfiction Books of Fall […]

Read More

Innovation is needed in the fight against rare diseases

Congress should encourage companies to repurpose existing drugs for rare diseases, potentially doubling the number of treatment options for patients. Lately, there has been a national uproar over the rising cost of medicine in the U.S. While this is an important public debate, it largely overlooks the critical importance of innovation, which is desperately needed […]

Read More